Farmakoterapia w Psychiatrii i Neurologii

Abstract

1/2021 vol. 37
Review paper

Two in one: simultaneous use of two long-acting antipsychotics in schizophrenia

  1. 3rd Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, Poland
Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (1), 45–51
Online publish date: 2021/11/17
View full text

Objectives

This paper aims to review the literature regarding the possible simultaneous use of two long-acting antipsychotics in the treatment of schizophrenia.

Selected literature review

Despite using the appropriate dose in antipsychotic treatment and continuing it for the necessary period, it happens that such treatment may be considered ineffective. In such a case, to supplement the clinical effect of antipsychotics, the addition of a second antipsychotic medication, mood stabiliser, or an antidepressant may be considered. If the inadequate response to the treatment results from poor medication adherence, the use of long-acting antipsychotic is re­commended. Some clinicians, however, try to use two long-acting antipsychotics simultaneously.

Conclusions

Sparse available data did not allow us to conclude that the simultaneous use of two long-acting antipsychotic agents significantly improves the outcome of pharmacological treatment of schizophrenia.

Share
without publication fees
without publication fees